02.01.2018 12:45:00
|
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018
NEW BRUNSWICK, N.J., Jan. 2, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2018 of $0.84 per share on the company's common stock. The dividend is payable on March 13, 2018 to shareholders of record at the close of business on February 27, 2018. The ex-dividend date is February 26, 2018.
About Johnson & Johnson
Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 134,100 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
View original content with multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-announces-quarterly-dividend-for-first-quarter-2018-300576247.html
SOURCE Johnson & Johnson
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
29.01.25 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: Hätte sich ein Investment in Johnson Johnson vor 5 Jahren inzwischen rentiert? (finanzen.at) | |
28.01.25 |
Dienstagshandel in New York: Dow Jones schlussendlich in Grün (finanzen.at) | |
28.01.25 |
NYSE-Handel: Dow Jones verbucht Zuschläge (finanzen.at) | |
28.01.25 |
Freundlicher Handel: Dow Jones am Mittag mit Gewinnen (finanzen.at) | |
27.01.25 |
NYSE-Handel: Dow Jones schlussendlich freundlich (finanzen.at) | |
27.01.25 |
Dow Jones aktuell: Dow Jones mit positivem Vorzeichen (finanzen.at) | |
27.01.25 |
NYSE-Handel: Dow Jones-Börsianer greifen am Montagmittag zu (finanzen.at) | |
27.01.25 |
Angespannte Stimmung in New York: Dow Jones notiert zum Handelsstart im Minus (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 147,68 | 0,49% |